Literature DB >> 931522

[Hyperphenylalaninaemia with normal phenylalanine-hydroxylase activity and a deficiency of tetrahydrobiopterin and dihydropteridine reductase].

F Rey, J P Harpey, R J Leeming, J A Blair, J Aicardi, J Rey.   

Abstract

Two cases of hyperphenylalaninemia with a normal activity of phenylalanine hydroxylase are described. No activity of DHP reductase was found in the first case, having very high biopterin levels in basal conditions and after intravenous perfusion of phenylalanine. In the other case, the DHP reductase activity is normal but plasma and urinary levels of the reduced forms of biopterin are largely lowered and do not increase during the phenylalanine load. Early substitutive treatment with L-dopa and 5-HTP in one of the cases avoided the development of the "progressive neurological illness unresponsive to dietary treatment" characterizing two variants. This raises the question of a liver biopsy in order to assay the hydroxylation enzyme activities when screening hyperphenylalaninemia whatever the type.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 931522

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  16 in total

1.  Malignant hyperphenylalaninaemia--current status (June 1977).

Authors:  D M Danks; K Bartholomé; B E Clayton; H Curtius; H Gröbe; S Kaufman; R Leeming; W Pfleiderer; H Rembold; F Rey
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

2.  Relationship between plasma and red cell biopterins in acute and chronic hyperphenylalaninaemia.

Authors:  R J Leeming; S K Hall; I M Surplice; A Green
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Tetrahydrobiopterin non-responsiveness in dihydropteridine reductase deficiency is associated with the presence of mutant protein.

Authors:  R G Cotton; I Jennings; G Bracco; A Ponzone; O Guardamagna
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

4.  Neurotransmitter therapy and diet in malignant phenylketonuria.

Authors:  A Ponzone; O Guardamagna; S Ferraris; S Biasetti; G Bracco; A Niederwieser
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

5.  Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: absence of phosphate-eliminating enzyme activity demonstrated in liver.

Authors:  A Niederwieser; W Leimbacher; H C Curtius; A Ponzone; F Rey; D Leupold
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

6.  Hyperphenylalaninaemia due to dihydropteridine reductase deficiency.

Authors:  H Gröbe; K Bartholome; S Milstien; S Kaufman
Journal:  Eur J Pediatr       Date:  1978-09-08       Impact factor: 3.183

7.  Dihydrobiopterin biosynthesis deficiency.

Authors:  J L Dhondt; B Leroux; J P Farriaux; C Largilliere; R J Leeming
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

8.  Tetrahydrobiopterin deficiency: assay for 6-pyruvoyl-tetrahydropterin synthase activity in erythrocytes, and detection of patients and heterozygous carriers.

Authors:  H Shintaku; A Niederwieser; W Leimbacher; H C Curtius
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

9.  GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia.

Authors:  A Niederwieser; N Blau; M Wang; P Joller; M Atarés; J Cardesa-Garcia
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

10.  Pterin metabolism in normal subjects and hyperphenylalaninaemic patients.

Authors:  J L Dhondt; J P Farriaux; C Largilliere; M Dautrevaux; P Ardouin
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.